Webinar: IL-13 is a Pathogenic Driver of COVID-19
DATE: Thursday, March 18, 2021
TIME: 19:00 AST | 20:00 GST
OVERVIEW: SARS-CoV-2 is currently causing the global COVID-19 pandemic and understanding mechanisms that contribute to disease severity will aid in protection from poor outcomes. For this reason, understanding the role of IL-13 and hyaluronan has important implications for possible therapies for COVID-19 and potentially other pulmonary diseases.
Join this webinar to learn about:
• Use of MILLIPLEX® Human Cytokine/Chemokine/Growth Factor Panel A to simultaneously profile 47 immune factors in COVID-19 plasma samples
• How analyte plasma profiles correlated with COVID-19 disease parameters, including the need for mechanical ventilation
• How a type 2 immune response, specifically IL-13, may play a role in COVID-19 severity.
Gulf Scientific Corporation (GSC) is a leading provider of complete laboratory solutions in the fields of analytical, life and material sciences. Founded in 1990, GSC is headquartered in Dubai, United Arab Emirates, with regional offices and supply chain distribution centers across the Middle East.